azd1222 95
AZD1222 The company AstraZeneca, an Anglo-Swedish company announced ( 2020) that it already has treatments to manufacture 400 million doses of an anti-ronavirus vaccine with which it has been experimenting with with a US agency in charge of vaccines. He has negotiated with the Serum Institute of India and other potential partners to increase production and distribution. AstraZeneca said it could manufacture one billion doses, as well as "guaranteeing shipments of a globally accessible vaccine". AstraZeneca also reached an agreement with the University of Oxford, where the vaccine was developed alongside the Oxford Vaccine Group, for a license for the vaccine, which will be known as AZD1222.